Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

New cardiovascular/renal agents under study at SmithKline Beecham

Feb. 29, 2000

Micardis enters large-scale efficacy trial

Feb. 29, 2000

Novel approach to cardiovascular disorders described by SB

Feb. 28, 2000

Phase III trial evaluating beraprost as treatment for moderate pulmonary hypertension

Feb. 28, 2000

Antianginal agents with minimal arrhythmogenic potential developed at Lafon

Feb. 25, 2000

Paladin licenses Uniprost to United Therapeutics in Canada

Feb. 23, 2000

Gene therapy improves age-related cardiac disorder in rats

Feb. 23, 2000

New phenethylsulfones synthesized at Celgene useful for inflammation, etc.

Feb. 23, 2000

JTV-519 may provide cardioprotection by mimicking preconditioning

Feb. 22, 2000

Effective new antianginal agents under study at Lafon

Feb. 22, 2000

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...